Keyword article
B12 Supplements for Cardiovascular Disease Prevention: Benefits and Limits
B12 supplements for cardiovascular disease prevention sound appealing because B12 can lower homocysteine in people who are deficient or borderline. The clinical trial story, however, is more cautious than the mechanism alone suggests.
What supplementation does well
When B12 is truly low, replacement can improve hematologic and neurologic consequences of deficiency and usually lowers homocysteine as part of the correction process.
That is a real benefit, especially in people with diet-related insufficiency, malabsorption, or medication-associated depletion.
What outcome trials have and have not shown
Large homocysteine-lowering trials have not shown a broad reduction in myocardial infarction or all-cause mortality just because B vitamins lowered the lab value.
Stroke outcomes appear more context dependent, with stronger benefit signals in lower-folate settings and weaker or absent effects where folic acid fortification is already common.
A practical supplement stance
Use supplements to correct an identified problem, not to promise guaranteed cardiovascular protection.
That keeps the message honest and aligns supplementation with the cause of the low result, the severity of symptoms, and the rest of the prevention plan.
Clinical takeaway
Supplement when deficiency is present or likely, but do not frame high-dose B12 as a stand-alone CVD prevention strategy.
Authority sources used
Vitamin B12 Fact Sheet for Health Professionals
NIH Office of Dietary Supplements
Summarizes B12 physiology, groups at risk of inadequacy, and the current cardiovascular evidence.
B Vitamins for Stroke Prevention
Stroke and Vascular Neurology (BMJ)
Reviews homocysteine-lowering trials and explains why stroke findings are more nuanced than broad CVD headlines.
Blog comments
Reader discussion
Visitors can post comments and one-level replies. Name, email, website, comment, and captcha are all required.
Today's usage
0 / 50